HUMA

SEC source: 0001247296-26-000005 · ownership.xml · derivative · entry 1

COWARD D SCOTT · CIK 0001247296 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2036-10-06

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on October 6, 2027, after which 1/48 of the option becomes exercisable on the 6th day of each month thereafter, with the option becoming fully vested on October 6, 2030.

SEC source: 0002156537-26-000004 · ownership.xml · derivative · entry 1

Kuznik Paul Brian · CIK 0002156537 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2036-10-06

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on October 6, 2027, after which 1/48 of the option becomes exercisable on the 6th day of each month thereafter, with the option becoming fully vested on October 6, 2030.

SEC source: 0001193125-26-391889 · ownership.xml · nonDerivative · entry 1

Jones Keith Anthony · CIK 0002026411 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

SEC source: 0001193125-26-361081 · ownership.xml · nonDerivative · entry 1

Jones Keith Anthony · CIK 0002026411 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

SEC source: 0001193125-26-356847 · ownership.xml · nonDerivative · entry 1

Jones Keith Anthony · CIK 0002026411 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

F1 · price: The price is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $0.590 to $0.596. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001104659-26-073609 · tm2617880-3_4seq1.xml · derivative · entry 1

Bamforth John Philip · CIK 0002026341 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2036-06-11

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 11, 2027, after which 1/48 of the option will become exercisable on the 11th of each month through June 11, 2030.

SEC source: 0001104659-26-073613 · tm2617880-6_4seq1.xml · derivative · entry 1

Jones Keith Anthony · CIK 0002026411 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2036-06-11

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 11, 2027, after which 1/48 of the option will become exercisable on the 11th of each month through June 11, 2030.

SEC source: 0001104659-26-073611 · tm2617880-5_4seq1.xml · derivative · entry 1

Green Charles Bruce · CIK 0001945398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2036-06-11

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 11, 2027, after which 1/48 of the option will become exercisable on the 11th of each month through June 11, 2030.

SEC source: 0001104659-26-073610 · tm2617880-4_4seq1.xml · derivative · entry 1

Seimetz Diane · CIK 0001930980 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2036-06-11

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 11, 2027, after which 1/48 of the option will become exercisable on the 11th of each month through June 11, 2030.

SEC source: 0001104659-26-073608 · tm2617880-2_4seq1.xml · derivative · entry 1

Brown Emery N. · CIK 0001878691 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2036-06-11

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 11, 2027, after which 1/48 of the option will become exercisable on the 11th of each month through June 11, 2030.

SEC source: 0001104659-26-073615 · tm2617880-8_4seq1.xml · derivative · entry 1

Niklason Laura E · CIK 0001878075 · Director · President, CEO and Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By spouse

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2036-06-11

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 11, 2027, after which 1/48 of the option will become exercisable on the 11th of each month through June 11, 2030.

SEC source: 0001104659-26-073607 · tm2617880-1_4seq1.xml · derivative · entry 1

Dougan Brady W · CIK 0001878020 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 80,000 shares

Expires 2036-06-11

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 11, 2027, after which 1/48 of the option will become exercisable on the 11th of each month through June 11, 2030.

SEC source: 0001104659-26-073616 · tm2617880-9_4seq1.xml · derivative · entry 1

Wallace Max N. · CIK 0001877453 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2036-06-11

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 11, 2027, after which 1/48 of the option will become exercisable on the 11th of each month through June 11, 2030.

SEC source: 0001104659-26-073620 · tm2617880-11_4seq1.xml · derivative · entry 1

Windham-Bannister Susan Richards · CIK 0001713760 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2036-06-11

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 11, 2027, after which 1/48 of the option will become exercisable on the 11th of each month through June 11, 2030.

SEC source: 0001104659-26-073617 · tm2617880-10_4seq1.xml · derivative · entry 1

Constantino Michael T. · CIK 0001817285 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2036-06-11

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 11, 2027, after which 1/48 of the option will become exercisable on the 11th of each month through June 11, 2030.

SEC source: 0001104659-26-073614 · tm2617880-7_4seq1.xml · derivative · entry 1

Sebelius Kathleen · CIK 0001654316 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2036-06-11

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 11, 2027, after which 1/48 of the option will become exercisable on the 11th of each month through June 11, 2030.

SEC source: 0001654316-26-000002 · ownership.xml · nonDerivative · entry 1

Sebelius Kathleen · CIK 0001654316 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,025

SEC source: 0001878193-26-000002 · ownership.xml · nonDerivative · entry 1

Sander Dale A. · CIK 0001878193 · CFO and Chief Corp. Dev. Off

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 267,213

F1 · security: Represents the number of shares of Common Stock sold under an automated program to cover the statutory tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. This sale was mandated by the Issuer's practice to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell-to-cover" transaction pursuant to a plan entered into by the Reporting Person for the purchase or sale of equity securities of the Issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), and therefore does not represent a discretionary sale by the Reporting Person.

SEC source: 0001817285-26-000002 · ownership.xml · nonDerivative · entry 1

Constantino Michael T. · CIK 0001817285 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,950

F1 · price: The price is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $0.8922 to $0.8958. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001916853-26-000002 · ownership.xml · nonDerivative · entry 1

Parikh Shamik J · CIK 0001916853 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 272,713

F1 · security: Represents the number of shares of Common Stock sold under an automated program to cover the statutory tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. This sale was mandated by the Issuer's practice to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell-to-cover" transaction pursuant to a plan entered into by the Reporting Person for the purchase or sale of equity securities of the Issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), and therefore does not represent a discretionary sale by the Reporting Person.

SEC source: 0001628280-25-052715 · wk-form4_1763419703.xml · derivative · entry 1

Niklason Laura E · CIK 0001878075 · Director · President, CEO and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 311,100

Underlying: Common Stock · 311,100 shares

Expires 2035-11-16

F1 · derivative.exercise_date: The first 1/3 of the option becomes exercisable on February 14, 2026, after which 1/3 of the option will become exercisable on November 16, 2026, and the remaining 1/3 of the option will become exercisable on November 16, 2027.

SEC source: 0001628280-25-052723 · wk-form4_1763419946.xml · nonDerivative · entry 1

Sander Dale A. · CIK 0001878193 · CFO and Chief Corp. Deve. Off.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 313,100

F1 · security: The Reporting Person was granted restricted stock units (RSUs), which represent a contingent right to receive one share of Common Stock for each RSU. The first 50% of the RSUs will vest on May 15, 2026, after which the remaining 50% of the RSUs will vest on May 15, 2027.

SEC source: 0001628280-25-052717 · wk-form4_1763419793.xml · derivative · entry 1

Dougan Brady W · CIK 0001878020 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By spouse

Disclosed balance after: 311,100

Underlying: Common Stock · 311,100 shares

Expires 2035-11-16

F1 · derivative.exercise_date: The first 1/3 of the option becomes exercisable on February 14, 2026, after which 1/3 of the option will become exercisable on November 16, 2026, and the remaining 1/3 of the option will become exercisable on November 16, 2027.

SEC source: 0001628280-25-052720 · wk-form4_1763419881.xml · nonDerivative · entry 1

Parikh Shamik J · CIK 0001916853 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 318,600

F1 · security: The Reporting Person was granted restricted stock units (RSUs), which represent a contingent right to receive one share of Common Stock for each RSU. The first 50% of the RSUs will vest on May 15, 2026, after which the remaining 50% of the RSUs will vest on May 15, 2027.

SEC source: 0001104659-25-081008 · tm2524042-1_4seq1.xml · nonDerivative · entry 3

Niklason Laura E · CIK 0001878075 · Director · President, CEO and Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Ayabudge LLC

Disclosed balance after: 0

F1 · shares: The sales were made by Ayabudge LLC, an entity controlled by Brady W. Dougan. The transactions enabled Mr. Dougan to pay down leverage while providing a mechanism for investors to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase. Dr. Niklason is treated as indirectly beneficially owning the shares sold, resulting in the requirement to file this Form 4. However, no shares directly beneficially owned by Dr. Niklason were sold in these transactions.

F4 · price: The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $1.53 to $1.69. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-25-081009 · tm2524042-2_4seq1.xml · nonDerivative · entry 3

Dougan Brady W · CIK 0001878020 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Ayabudge LLC

Disclosed balance after: 0

F1 · shares: The sales were made by Ayabudge LLC, an entity controlled by Brady W. Dougan. The transactions enabled Mr. Dougan to pay down leverage while providing a mechanism for investors to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase.

F4 · price: The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $1.53 to $1.69. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-25-081008 · tm2524042-1_4seq1.xml · nonDerivative · entry 2

Niklason Laura E · CIK 0001878075 · Director · President, CEO and Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Ayabudge LLC

Disclosed balance after: 591,685

F1 · shares: The sales were made by Ayabudge LLC, an entity controlled by Brady W. Dougan. The transactions enabled Mr. Dougan to pay down leverage while providing a mechanism for investors to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase. Dr. Niklason is treated as indirectly beneficially owning the shares sold, resulting in the requirement to file this Form 4. However, no shares directly beneficially owned by Dr. Niklason were sold in these transactions.

F3 · price: The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $1.57 to $1.76. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-25-081009 · tm2524042-2_4seq1.xml · nonDerivative · entry 2

Dougan Brady W · CIK 0001878020 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Ayabudge LLC

Disclosed balance after: 591,685

F1 · shares: The sales were made by Ayabudge LLC, an entity controlled by Brady W. Dougan. The transactions enabled Mr. Dougan to pay down leverage while providing a mechanism for investors to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase.

F3 · price: The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $1.57 to $1.76. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-25-081008 · tm2524042-1_4seq1.xml · nonDerivative · entry 1

Niklason Laura E · CIK 0001878075 · Director · President, CEO and Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Ayabudge LLC

Disclosed balance after: 1,691,685

F1 · shares: The sales were made by Ayabudge LLC, an entity controlled by Brady W. Dougan. The transactions enabled Mr. Dougan to pay down leverage while providing a mechanism for investors to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase. Dr. Niklason is treated as indirectly beneficially owning the shares sold, resulting in the requirement to file this Form 4. However, no shares directly beneficially owned by Dr. Niklason were sold in these transactions.

F2 · price: The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $1.79 to $1.92. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-25-081009 · tm2524042-2_4seq1.xml · nonDerivative · entry 1

Dougan Brady W · CIK 0001878020 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Ayabudge LLC

Disclosed balance after: 1,691,685

F1 · shares: The sales were made by Ayabudge LLC, an entity controlled by Brady W. Dougan. The transactions enabled Mr. Dougan to pay down leverage while providing a mechanism for investors to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase.

F2 · price: The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $1.79 to $1.92. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001818382-25-000109 · wk-form4_1750105851.xml · derivative · entry 1

Bamforth John Philip · CIK 0002026341 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 12, 2026, after which 1/48 of the option will become exercisable on the 12th of each month through June 12, 2029.

SEC source: 0001818382-25-000116 · wk-form4_1750105933.xml · derivative · entry 1

Jones Keith Anthony · CIK 0002026411 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 12, 2026, after which 1/48 of the option will become exercisable on the 12th of each month through June 12, 2029.

SEC source: 0001818382-25-000111 · wk-form4_1750105874.xml · derivative · entry 1

Green Charles Bruce · CIK 0001945398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 12, 2026, after which 1/48 of the option will become exercisable on the 12th of each month through June 12, 2029.

SEC source: 0001818382-25-000108 · wk-form4_1750105839.xml · derivative · entry 1

Seimetz Diane · CIK 0001930980 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 12, 2026, after which 1/48 of the option will become exercisable on the 12th of each month through June 12, 2029.

SEC source: 0001818382-25-000117 · wk-form4_1750105947.xml · derivative · entry 1

Brown Emery N. · CIK 0001878691 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 12, 2026, after which 1/48 of the option will become exercisable on the 12th of each month through June 12, 2029.

SEC source: 0001818382-25-000113 · wk-form4_1750105897.xml · derivative · entry 5

Niklason Laura E · CIK 0001878075 · Director · President, CEO and Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By spouse

Disclosed balance after: 0

Underlying: Common Stock · 80,000 shares

Expires 2035-06-12

F2 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 12, 2026, after which 1/48 of the option will become exercisable on the 12th of each month through June 12, 2029.

SEC source: 0001818382-25-000112 · wk-form4_1750105886.xml · derivative · entry 5

Dougan Brady W · CIK 0001878020 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 80,000 shares

Expires 2035-06-12

F2 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 12, 2026, after which 1/48 of the option will become exercisable on the 12th of each month through June 12, 2029.

SEC source: 0001818382-25-000115 · wk-form4_1750105920.xml · derivative · entry 1

Wallace Max N. · CIK 0001877453 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 12, 2026, after which 1/48 of the option will become exercisable on the 12th of each month through June 12, 2029.

SEC source: 0001818382-25-000118 · wk-form4_1750105960.xml · derivative · entry 1

Pope Todd · CIK 0001584367 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 12, 2026, after which 1/48 of the option will become exercisable on the 12th of each month through June 12, 2029.

SEC source: 0001818382-25-000114 · wk-form4_1750105909.xml · derivative · entry 1

Windham-Bannister Susan Richards · CIK 0001713760 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 12, 2026, after which 1/48 of the option will become exercisable on the 12th of each month through June 12, 2029.

SEC source: 0001818382-25-000110 · wk-form4_1750105863.xml · derivative · entry 1

Constantino Michael T. · CIK 0001817285 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 12, 2026, after which 1/48 of the option will become exercisable on the 12th of each month through June 12, 2029.

SEC source: 0001818382-25-000107 · wk-form4_1750105821.xml · derivative · entry 1

Sebelius Kathleen · CIK 0001654316 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 12, 2026, after which 1/48 of the option will become exercisable on the 12th of each month through June 12, 2029.

SEC source: 0001818382-25-000052 · wk-form4_1744747408.xml · nonDerivative · entry 1

Scheessele William John · CIK 0001879378 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,018

SEC source: 0001818382-25-000050 · wk-form4_1744635615.xml · nonDerivative · entry 1

Sander Dale A. · CIK 0001878193 · CFO and Chief Corp. Deve. Off.

10b5-1 filing: No plan indicated

Ownership: Indirect · By spouse

Disclosed balance after: 40,600

SEC source: 0001818382-25-000049 · wk-form4_1744635605.xml · nonDerivative · entry 1

Parikh Shamik J · CIK 0001916853 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

SEC source: 0001818382-25-000045 · wk-form4_1744143336.xml · nonDerivative · entry 1

Green Charles Bruce · CIK 0001945398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,400

F1 · price: The price is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $1.285 to $1.2891. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001818382-25-000046 · wk-form4_1744143346.xml · nonDerivative · entry 1

Sebelius Kathleen · CIK 0001654316 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,207

SEC source: 0001818382-25-000044 · wk-form4_1744143324.xml · nonDerivative · entry 1

Constantino Michael T. · CIK 0001817285 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,950

F1 · price: The price is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $1.255 to $1.26. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001818382-25-000020 · wk-form4_1737668091.xml · derivative · entry 1

Scheessele William John · CIK 0001879378 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 283,101

Underlying: Common Stock · 283,101 shares

Expires 2035-01-21

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on January 21, 2026, after which 1/48 of the option will become exercisable on the 21st of each month through January 21, 2029.

SEC source: 0001818382-25-000017 · wk-form4_1737668058.xml · derivative · entry 1

Niklason Laura E · CIK 0001878075 · Director · President, CEO and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,130,311

Underlying: Common Stock · 1,130,311 shares

Expires 2035-01-21

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on January 21, 2026, after which 1/48 of the option will become exercisable on the 21st of each month through January 21, 2029.